Infusion Therapy

AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and Pure Healthcare, a leading national medical group that delivers healthcare services for individuals with complex chronic conditions such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, Alzheimer’s disease and other autoimmune conditions, announce the completion of their previously announced merger. “This combination […]

Shore Capital Partners (“Shore” or “Shore Capital”), a Chicago-based private equity firm with offices in Nashville, announces the merger of Reliant Healthcare (“Reliant”) and Care Fusion Rx (“Care Fusion”), a platform investment of Shore Capital’s Healthcare Advantage Fund (“Advantage Fund” or the “Fund”). The unified infusion therapy platform is designed to deliver comprehensive services across

One Equity Partners (“OEP”), a middle market private equity firm, announces it has exited its investment in InfuCare Rx, Inc. (“InfuCare” or the “Company”) through a strategic founder-led equity buyback. Founded in 2014, InfuCare has become one of the nation’s largest privately held independent providers of specialty infusion therapies at home as well as alternate

RC Capital (RCC) completed the successful exit of FlexCare Infusion Centers. This milestone underscores RC Capital’s ongoing commitment to building market-leading healthcare platforms that enhance patient experiences and outcomes, expand access to care, and reduce costs across the healthcare system. At the time of investment, FlexCare operated just two clinics in Oklahoma City. Together, RCC

BioMatrix Infusion Pharmacy announces the successful acquisition of LUX Infusion, Alaska’s premier ambulatory infusion center business, effective October 17, 2025. LUX operates three state-of-the-art infusion centers across Alaska, delivering high-quality, patient-centered care and earning a strong reputation for clinical excellence and trusted provider and payer partnerships. With this acquisition, BioMatrix continues to evolve into one